Logo

Invitrogen’s Sale of BioReliance Topped Most-Read GenomeWeb News Stories Last Week

Feb 19, 2007
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 16.
 
1. Invitrogen to Sell BioReliance for $210M; Posts Weak Revenue Gain and $100M Loss in Q4 (from Feb. 14)
 
2. House Bill Seeks to Prohibit 'All' New Human Genome Patenting (from Feb. 16)
 
3. Qiagen Licenses RT-PCR IP From Roche, Ortho Clinical Diagnostics (from Feb. 15)
 
4. Illumina Makes Brass Changes; ABI's SDS Manager Joins Gen-Probe as COO; Former Affy CFO Joins Entelos Board; and Others (from Feb. 16)
 
5. Illumina to Offer $325M in Convertible Notes; Will Use $200M to Repurchase Shares (from Feb. 12)
Breaking News
The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.